We are live on ! Find out more
CA

Cortland Associates Portfolio holdings

AUM $692M
1-Year Est. Return 5%
This Fund
S&P 500
This Quarter Est. Return
+12.23%
1 Year Est. Return
-5%
3 Year Est. Return
+57.07%
5 Year Est. Return
+61.48%
10 Year Est. Return
+413.35%
AUM
$879M
AUM Growth
+$56.2M
Cap. Flow
-$26.9M
Cap. Flow %
-3.06%
Top 10 Hldgs %
65.53%
Holding
60
New
3
Increased
12
Reduced
28
Closed
1

Top Buys

Rank Stock Value
1
FA icon
First Advantage
FA
+$24.6M
2
LB
LandBridge Co
LB
+$9.04M
3
OEF icon
iShares S&P 100 ETF
OEF
+$200K
4
PM icon
Philip Morris
PM
+$18.2K
5
MO icon
Altria Group
MO
+$16.8K

Top Sells

Rank Stock Value
1
TPL icon
Texas Pacific Land
TPL
+$32.3M
2
CI icon
Cigna
CI
+$15.5M
3
FISV
Fiserv Inc
FISV
+$1.71M
4
BKNG icon
Booking.com
BKNG
+$1.42M
5
V icon
Visa
V
+$1.06M

Sector Composition

Rank Sector Weight
1 Financials 34.32%
2 Technology 17.65%
3 Consumer Discretionary 15.58%
4 Healthcare 8.84%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
51
iShares Russell 2000 ETF
IWM
$83B
$245K 0.03%
1,110
NVDA icon
52
NVIDIA
NVDA
$5.42T
$242K 0.03%
1,800
-50
-3% -$6.89K
ADT icon
53
ADT
ADT
$5.58B
$225K 0.03%
32,616
-2,800
-8% -$20.4K
K
54
DELISTED
Kellanova
K
$217K 0.02%
2,675
+15
+0.6% +$1.21K
OEF icon
55
iShares S&P 100 ETF
OEF
$20.6B
$202K 0.02%
+700
New +$200K
PFE icon
56
Pfizer
PFE
$153B
-7,367
Closed -$213K

Similar funds

Cortland Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Cortland Associates held 60 positions worth $879M, up 6.8% from $823M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Cortland Associates withdrew a net $26.9M in Q4 2024, closing 1 position and reducing 28 holdings. Its most notable exit was Pfizer, an estimated $213K position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cortland Associates opened a new position in First Advantage worth $24.3M.

  • Cortland Associates's largest Q4 2024 buy was First Advantage: 1,298,855 shares worth $24.3M.
  • Cortland Associates added most to Philip Morris in Q4 2024, an estimated $18.2K increase.
  • Cortland Associates's biggest Q4 2024 reduction was Texas Pacific Land, cutting an estimated $32.3M.
  • Cortland Associates fully exited Pfizer in Q4 2024, selling an estimated $213K.
  • Cortland Associates's ten largest holdings make up 66% of its $879M portfolio in Q4 2024.
  • Cortland Associates opened 3 new positions and closed 1 in Q4 2024.
  • Cortland Associates's portfolio value rose 6.8% quarter-over-quarter to $879M.

Based on Cortland Associates's 13F filing for Q4 2024, filed 23 Jan 2025.